Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Gains from Sales and Divestitures (2017 - 2025)

Chemours' quarterly Gains from Sales and Divestitures came in at $3000.0 in Q4 2025, down 97.09% year-on-year from $103000.0 in Q4 2024, and down 97.09% quarter-over-quarter from $103000.0 in Q4 2024.

Chemours has reported Gains from Sales and Divestitures for 9 years, with the latest figure at $3000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Gains from Sales and Divestitures fell 97.09% year-over-year to $3000.0; the trailing twelve-month figure through Dec 2025 stood at $3000.0 (down 97.09% YoY), and the FY2025 full-year result was $3000.0, down 97.09% from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 stood at $3000.0, down from $103000.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $410000.0 in Q4 2023, with the low at $3000.0 in Q4 2025.
  • Average Gains from Sales and Divestitures over 5 years is $183400.0, with a median of $188000.0 recorded in 2021.
  • Year-over-year, Gains from Sales and Divestitures surged 92.49% in 2023 and slumped 97.09% in 2025.
  • Tracing CC's Gains from Sales and Divestitures over 5 years: stood at $188000.0 in 2021, then climbed by 13.3% to $213000.0 in 2022, then surged by 92.49% to $410000.0 in 2023, then sank by 74.88% to $103000.0 in 2024, then tumbled by 97.09% to $3000.0 in 2025.
  • The last three Gains from Sales and Divestitures figures came in at $3000.0 (Q4 2025), $103000.0 (Q4 2024), and $410000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Linde 230.79 Bn 226.84 Bn 4.26 Bn
2 Chemical & Mining Co Of Chile 127.66 Bn 124.93 Bn 778.60 Mn
3 Sherwin Williams 72.51 Bn 72.30 Bn 2.78 Bn
4 Ecolab 70.96 Bn 70.34 Bn 1.85 Bn
5 Air Products & Chemicals 62.15 Bn 63.70 Bn 987.40 Mn
6 Ppg Industries 25.04 Bn 23.57 Bn 1.66 Bn
7 LyondellBasell Industries 21.62 Bn 21.73 Bn 701.00 Mn
8 Albemarle 20.26 Bn 19.42 Bn 500.97 Mn
9 DuPont de Nemours 19.45 Bn 19.56 Bn 602.00 Mn
10 Chemours 3.38 Bn 3.38 Bn 212.00 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3,000.00
Dec 31, 2025 3,000.00
Dec 31, 2024 103,000.00
Dec 31, 2024 103,000.00
Dec 31, 2023 410,000.00
Dec 31, 2023 410,000.00
Dec 31, 2022 213,000.00
Dec 31, 2022 213,000.00
Dec 31, 2021 188,000.00
Dec 31, 2021 188,000.00
Dec 31, 2020 161,000.00
Dec 31, 2020 161,000.00
Dec 31, 2019 761,000.00
Dec 31, 2019 761,000.00
Sep 30, 2019 1.52 Mn
Sep 30, 2019 1.52 Mn
Jun 30, 2019 1.52 Mn
Jun 30, 2019 1.52 Mn
Mar 31, 2019 1.52 Mn
Mar 31, 2019 1.52 Mn
Dec 31, 2018 1.03 Mn
Dec 31, 2018 1.03 Mn
Dec 31, 2017 1.32 Mn
Dec 31, 2017 1.32 Mn